plerixafor has been researched along with Primary Myelofibrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bianchi, DA; Blair, EA; Buck, CB; Calvo, KR; Cho, E; Gardner, PJ; Landon, EM; Liu, Q; McDermott, DH; Murphy, PM; Neves, JF; Pastrana, DV; Pittaluga, S; Silva, SL; Trout, HH; Velez, D | 1 |
1 other study(ies) available for plerixafor and Primary Myelofibrosis
Article | Year |
---|---|
Plerixafor for the Treatment of WHIM Syndrome.
Topics: Benzylamines; Bone Marrow; Bone Marrow Examination; Cyclams; Fatal Outcome; Heterocyclic Compounds; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Neoplasms, Squamous Cell; Phenotype; Primary Immunodeficiency Diseases; Primary Myelofibrosis; Receptors, CXCR4; Warts | 2019 |